Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 5:20 pm Sale |
2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ORBIMED ADVISORS LLC | 0 0.000% |
-350,641 (Position Closed) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Commodore Capital LP | 0 0.000% |
-348,530 (Position Closed) |
Filing History |
| 2023-02-14 3:32 pm Sale |
2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 0 0.000% |
-391,209 (Position Closed) |
Filing History |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
BlackRock Inc. BLK |
408,932 5.900% |
12,459 (+3.14%) |
Filing History |
| 2023-02-01 1:49 pm Sale |
2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
FRANKLIN RESOURCES INC BEN |
0 0.000% |
-337,267 (Position Closed) |
Filing History |
| 2022-08-12 5:15 pm Sale |
2022-07-22 | 13D | VistaGen Therapeutics, Inc. VTGN |
Growth Equity Opportunities 17 LLC | 0 0.000% |
-543,420 (Position Closed) |
Filing History |
| 2022-07-08 4:05 pm Purchase |
2022-04-06 | 13G | VistaGen Therapeutics, Inc. VTGN |
Venrock Healthcare Capital Partners II, L.P. | 689,910 10.000% |
155,000 (+28.98%) |
Filing History |
| 2022-04-14 4:42 pm Purchase |
2022-04-04 | 13G | VistaGen Therapeutics, Inc. VTGN |
Commodore Capital LP | 348,530 5.100% |
348,530 (New Position) |
Filing History |
| 2022-02-15 2:51 pm Sale |
2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 391,209 5.900% |
-24,290 (-5.85%) |
Filing History |
| 2022-02-14 4:20 pm Purchase |
2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Venrock Healthcare Capital Partners II, L.P. | 534,910 8.000% |
60,235 (+12.69%) |
Filing History |
| 2022-02-11 4:58 pm Purchase |
2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ORBIMED ADVISORS LLC | 350,641 5.300% |
24,681 (+7.57%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
BlackRock Inc. BLK |
396,473 6.000% |
396,473 (New Position) |
Filing History |
| 2022-02-04 10:54 am Purchase |
2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
FRANKLIN RESOURCES INC BEN |
337,267 5.100% |
337,267 (New Position) |
Filing History |
| 2021-04-29 10:17 am Purchase |
2021-03-26 | 13D | VistaGen Therapeutics, Inc. VTGN |
Growth Equity Opportunities 17 LLC | 543,420 8.600% |
231,420 (+74.17%) |
Filing History |
| 2021-03-22 06:06 am Purchase |
2021-03-12 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 415,499 8.400% |
165,499 (+66.20%) |
Filing History |
| 2021-02-16 4:11 pm Purchase |
2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Venrock Healthcare Capital Partners II, L.P. | 474,675 9.990% |
474,675 (New Position) |
Filing History |
| 2021-02-16 06:14 am Purchase |
2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 250,000 5.400% |
250,000 (New Position) |
Filing History |
| 2021-02-12 5:12 pm Purchase |
2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ORBIMED ADVISORS LLC | 325,960 6.900% |
325,960 (New Position) |
Filing History |
| 2021-01-22 5:26 pm Purchase |
2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Rosalind Advisors, Inc. | 179,237 4.800% |
45,904 (+34.43%) |
Filing History |
| 2021-01-04 06:00 am Purchase |
2020-12-22 | 13D | VistaGen Therapeutics, Inc. VTGN |
Growth Equity Opportunities 17 LLC | 312,000 6.800% |
312,000 (New Position) |
Filing History |